These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 23034952)
41. Antibodies to myelin basic protein, myelin oligodendrocytes peptides, alpha-beta-crystallin, lymphocyte activation and cytokine production in patients with multiple sclerosis. Vojdani A; Vojdani E; Cooper E J Intern Med; 2003 Oct; 254(4):363-74. PubMed ID: 12974875 [TBL] [Abstract][Full Text] [Related]
42. Time course of T-cell responses to MOG and MBP in patients with clinically isolated syndromes. Correale J; de los Milagros Bassani Molinas M J Neuroimmunol; 2003 Mar; 136(1-2):162-71. PubMed ID: 12620656 [TBL] [Abstract][Full Text] [Related]
43. Immunologic Effects of Metformin and Pioglitazone Treatment on Metabolic Syndrome and Multiple Sclerosis. Negrotto L; Farez MF; Correale J JAMA Neurol; 2016 May; 73(5):520-8. PubMed ID: 26953870 [TBL] [Abstract][Full Text] [Related]
44. Evaluation of ovarian reserve and the assisted reproductive technology (ART) cycles' outcome as well as the relapse rate within one year after ART in women with multiple sclerosis: a case-control study. Arabipoor A; Moini A; Nabavi SM; Mohiti S; Mashayekhi M; Zolfaghari Z J Ovarian Res; 2024 Aug; 17(1):165. PubMed ID: 39138488 [TBL] [Abstract][Full Text] [Related]
45. High dose antigen treatment with a peptide epitope of myelin basic protein modulates T cells in multiple sclerosis patients. Loo EW; Krantz MJ; Agrawal B Cell Immunol; 2012 Nov; 280(1):10-5. PubMed ID: 23246830 [TBL] [Abstract][Full Text] [Related]
46. Evidence for cytokine dysregulation in multiple sclerosis: peripheral blood mononuclear cell production of pro-inflammatory and anti-inflammatory cytokines during relapse and remission. Hollifield RD; Harbige LS; Pham-Dinh D; Sharief MK Autoimmunity; 2003 May; 36(3):133-41. PubMed ID: 12911279 [TBL] [Abstract][Full Text] [Related]
48. B Lymphocytes in Multiple Sclerosis: Bregs and BTLA/CD272 Expressing-CD19+ Lymphocytes Modulate Disease Severity. Piancone F; Saresella M; Marventano I; La Rosa F; Zoppis M; Agostini S; Longhi R; Caputo D; Mendozzi L; Rovaris M; Clerici M Sci Rep; 2016 Jul; 6():29699. PubMed ID: 27412504 [TBL] [Abstract][Full Text] [Related]
49. Cytokine secretion and nitric oxide production by mononuclear cells of patients with multiple sclerosis. Sarchielli P; Orlacchio A; Vicinanza F; Pelliccioli GP; Tognoloni M; Saccardi C; Gallai V J Neuroimmunol; 1997 Dec; 80(1-2):76-86. PubMed ID: 9413261 [TBL] [Abstract][Full Text] [Related]
50. Interferon gamma responses to myelin peptides in multiple sclerosis correlate with a new clinical measure of disease progression. Moldovan IR; Rudick RA; Cotleur AC; Born SE; Lee JC; Karafa MT; Pelfrey CM J Neuroimmunol; 2003 Aug; 141(1-2):132-40. PubMed ID: 12965264 [TBL] [Abstract][Full Text] [Related]
51. Vitamin D3 administration to MS patients leads to increased serum levels of latency activated peptide (LAP) of TGF-beta. Åivo J; Hänninen A; Ilonen J; Soilu-Hänninen M J Neuroimmunol; 2015 Mar; 280():12-5. PubMed ID: 25773149 [TBL] [Abstract][Full Text] [Related]
52. Interferon beta treatment of multiple sclerosis increases serum interleukin-7. Lundström W; Hermanrud C; Sjöstrand M; Brauner S; Wahren-Herlenius M; Olsson T; Karrenbauer V; Hillert J; Fogdell-Hahn A Mult Scler; 2014 Nov; 20(13):1727-36. PubMed ID: 24821684 [TBL] [Abstract][Full Text] [Related]
53. Optic neuritis is associated with myelin basic protein and proteolipid protein reactive cells producing interferon-gamma, interleukin-4 and transforming growth factor-beta. Link J; Söderström M; Kostulas V; Olsson T; Höjeberg B; Ljungdahl A; Link H J Neuroimmunol; 1994 Jan; 49(1-2):9-18. PubMed ID: 7507500 [TBL] [Abstract][Full Text] [Related]
54. MOBP-specific cellular immune responses are weaker than MOG-specific cellular immune responses in patients with multiple sclerosis and healthy subjects. Jilek S; Schluep M; Pantaleo G; Du Pasquier RA Neurol Sci; 2013 Apr; 34(4):539-43. PubMed ID: 22752855 [TBL] [Abstract][Full Text] [Related]
55. Pattern of cytokine secretion by peripheral blood cells of patients with multiple sclerosis in Brazil. da Costa P; Yasuda CL; Scagliusi SM; Diaz-Bardales BM; Maciel E; Damasceno BP; Blotta MH; Tilbery CP; Santos LM Mult Scler; 2000 Oct; 6(5):293-9. PubMed ID: 11064437 [TBL] [Abstract][Full Text] [Related]
56. Severe multiple sclerosis reactivation after gonadotropin treatment. Torkildsen Ø; Holmøy T; Myhr KM Mult Scler Relat Disord; 2018 May; 22():38-40. PubMed ID: 29525298 [TBL] [Abstract][Full Text] [Related]
57. Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis. Mohr DC; Goodkin DE; Islar J; Hauser SL; Genain CP Arch Neurol; 2001 Jul; 58(7):1081-6. PubMed ID: 11448297 [TBL] [Abstract][Full Text] [Related]
58. Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS. Huber AK; Wang L; Han P; Zhang X; Ekholm S; Srinivasan A; Irani DN; Segal BM Neurology; 2014 Oct; 83(17):1500-7. PubMed ID: 25253754 [TBL] [Abstract][Full Text] [Related]
59. Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis. Elong Ngono A; Lepetit M; Reindl M; Garcia A; Guillot F; Genty A; Chesneau M; Salou M; Michel L; Lefrere F; Schanda K; Imbert-Marcille BM; Degauque N; Nicot A; Brouard S; Laplaud DA; Soulillou JP J Immunol Res; 2015; 2015():673503. PubMed ID: 26090495 [TBL] [Abstract][Full Text] [Related]